乳痛症经常伴有乳房纤维囊性病变,其原因不明,至今尚无有效的治疗方法。作者用双盲交叉法研究了溴隐亭对乳痛症的疗效。作者对10例患有严重乳痛,经触诊,乳房摄片,组织学检查明确有乳房弥漫性纤维囊性变的妇女进行了研究,其中1例有乳溢,无明显的月经前期综合征的特征,出现乳痛的时间为6个月～几年。用双盲法试验进行随机分配,一部分用溴隐亭,一部分用安慰剂,治疗时间每例均2月,第1周剂量为1粒(溴隐亭2.5mg 或安慰剂),在治疗前1周及治疗整个期间记录每例乳痛存在与否和疼痛的强度。以后每天2粒,血清泌乳素在试验前,试验进行中和试验后均进行了测定,范围是3.0～13.5μg/L。 Breast disorders often accompanied by breast fibrocystic disease, the reason is unknown, so far there is no effective treatment. The authors used double-blind crossover method to study the efficacy of bromocriptine on breast cancer. The authors studied 10 women with severe malabsorption, palpation, mammography, and histologic examination of diffuse cystic fibrosis in the breast, one of whom had anastomosis with no significant premenstrual syndrome The characteristics of breast milk appear for 6 months to several years. A randomized, double-blind trial was performed with bromocriptine in part and placebo in place for a period of 2 months in each case, with a dose of 1 in the first week (bromocriptine 2.5 mg or placebo), 1 Record the intensity of the presence or absence of pain and the pain in each case throughout the week and treatment. After a day 2, serum prolactin in the test before and after the test were carried out in the determination of the test, the range is 3.0 ~ 13.5μg / L.